Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levothyroxine in dialysis patients with subclinical hypothyroidism
NCT03191188Unknown
- Sponsor
- University of California, Irvine
- Start
- Jul 2017
- Primary completion
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of levothyroxine sodium in hypothyroidism, sponsored by University of California, Irvine. Primary endpoint: Achievement of target thyrotropin levels at 12 weeks. Status: unknown.
02
Drugs
levothyroxine sodium
03
Conditions
hypothyroidism
Beyond the preview
Go deeper on NCT03191188.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03191188.